相似文献
1
ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research.实施研究以开发针对艾滋病毒感染者的干预措施（PRECluDE 联盟）：通过实施研究来防治艾滋病毒感染者的慢性病共病。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):79-91. doi: 10.1016/j.pcad.2020.03.006. Epub 2020 Mar 19.
2
Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.降低 HIV 感染者的心血管风险：HIV 行为经济学研究中增加他汀类药物处方的理由和设计（INSPIRE）随机对照试验。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):109-117. doi: 10.1016/j.pcad.2020.02.012. Epub 2020 Feb 19.
3
Enhancing patient and organizational readiness for cardiovascular risk reduction among Black and Latinx patients living with HIV: Study protocol.提高接受抗逆转录病毒治疗的黑人和拉丁裔艾滋病毒感染者降低心血管风险的患者和组织准备度：研究方案。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):101-108. doi: 10.1016/j.pcad.2020.02.014. Epub 2020 Feb 25.
4
Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa.撒哈拉以南非洲地区艾滋病毒感染者的心血管疾病预防。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):149-159. doi: 10.1016/j.pcad.2020.02.004. Epub 2020 Feb 5.
5
Prevention of stroke in people living with HIV.预防 HIV 感染者发生中风。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):160-169. doi: 10.1016/j.pcad.2020.01.006. Epub 2020 Jan 31.
6
Physical activity and exercise to improve cardiovascular health for adults living with HIV.身体活动和锻炼改善艾滋病毒感染者的心血管健康。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):178-183. doi: 10.1016/j.pcad.2020.01.005. Epub 2020 Jan 31.
7
Prevention as treatment: A bold vision for improving the cardiovascular health of people living with HIV.预防即治疗：改善HIV感染者心血管健康的大胆愿景。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):77-78. doi: 10.1016/j.pcad.2020.02.011. Epub 2020 Feb 20.
8
Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV.有和没有 HIV 的退伍军人中戒烟药物治疗的接受情况和预测因素。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):118-124. doi: 10.1016/j.pcad.2020.01.003. Epub 2020 Jan 24.
9
Protocol paper: Stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV.方案文件：采用逐步楔形集群随机试验将 ABCS 转化为优化艾滋病毒感染者心血管护理。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):125-133. doi: 10.1016/j.pcad.2020.02.003. Epub 2020 Feb 5.
10
Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.为患有 HIV 的历史上被边缘化的种族和族裔群体预防心血管疾病：文献综述。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):142-148. doi: 10.1016/j.pcad.2020.02.006. Epub 2020 Feb 11.
引用本文的文献
1
Enhancing Cardiovascular Health in Southeastern United States for Underrepresented Racial and Ethnic Minorities With HIV: A Qualitative Inquiry Using the Health Belief Model.在美国东南部提高感染艾滋病毒的代表性不足的种族和族裔少数群体的心血管健康：一项基于健康信念模型的定性调查
J Assoc Nurses AIDS Care. 2025 Jul 29. doi: 10.1097/JNC.0000000000000576.
2
Specialty Care Referral for Underrepresented Minorities Living with HIV in the United States: Experiences, Barriers, and Facilitators.美国少数族裔 HIV 感染者的专科医疗转介：经验、障碍和促进因素。
AIDS Patient Care STDS. 2024 Jun;38(6):259-266. doi: 10.1089/apc.2024.0066. Epub 2024 Jun 13.
3
Epigenetic aging in older people living with HIV in Eswatini: a pilot study of HIV and lifestyle factors and epigenetic aging.在斯威士兰艾滋病毒感染者中老年人的表观遗传衰老：一项关于艾滋病毒和生活方式因素与表观遗传衰老的初步研究。
Clin Epigenetics. 2024 Feb 26;16(1):32. doi: 10.1186/s13148-024-01629-7.
4
Epigenetic aging in older people living with HIV in Eswatini: a pilot study of HIV and lifestyle factors and epigenetic aging.斯威士兰感染艾滋病毒的老年人的表观遗传衰老：一项关于艾滋病毒、生活方式因素与表观遗传衰老的试点研究
Res Sq. 2023 Oct 5:rs.3.rs-3389208. doi: 10.21203/rs.3.rs-3389208/v1.
5
Drug-drug interactions of Integrase Strand Transfer Inhibitors among older people living with HIV: Interazioni farmacologiche degli inibitori delle integrase tra le persone anziane che vivono con HIV.老年HIV感染者中整合酶链转移抑制剂的药物相互作用：老年HIV感染者中整合酶抑制剂的药物相互作用
J HIV Ageing. 2022 Jun;7(2):29-36. doi: 10.19198/jha31533.
6
Public Engagement with Biotechnology Inside and Outside the Classroom: Community-Focused Approaches.课堂内外公众对生物技术的参与：以社区为中心的方法。
GEN Biotechnol. 2022 Aug;1(4):346-354. doi: 10.1089/genbio.2022.0024. Epub 2022 Aug 18.
7
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.HIV 感染者和已知动脉粥样硬化性心血管疾病患者中他汀类药物处方的差异。
Am Heart J. 2022 Jul;249:12-22. doi: 10.1016/j.ahj.2022.03.006. Epub 2022 Mar 19.
8
Statin usage and cardiovascular risk among people living with HIV in the U.S. Military HIV Natural History Study.美国军事艾滋病毒自然史研究中，艾滋病毒感染者中他汀类药物的使用与心血管风险。
HIV Med. 2022 Mar;23(3):249-258. doi: 10.1111/hiv.13195. Epub 2021 Oct 26.
9
HIV-Related Stigma Research as a Priority at the National Institutes of Health.将 HIV 相关污名研究作为美国国立卫生研究院的优先事项。
AIDS Behav. 2022 Jan;26(Suppl 1):5-26. doi: 10.1007/s10461-021-03260-6. Epub 2021 Apr 22.
10
The influence of healthcare financing on cardiovascular disease prevention in people living with HIV.医疗保健融资对 HIV 感染者心血管疾病预防的影响。
BMC Public Health. 2020 Nov 23;20(1):1768. doi: 10.1186/s12889-020-09896-8.
本文引用的文献
1
Deaths: Final Data for 2017.死亡：2017年最终数据。
Natl Vital Stat Rep. 2019 Jun;68(9):1-77.
2
Enhancing patient and organizational readiness for cardiovascular risk reduction among Black and Latinx patients living with HIV: Study protocol.提高接受抗逆转录病毒治疗的黑人和拉丁裔艾滋病毒感染者降低心血管风险的患者和组织准备度：研究方案。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):101-108. doi: 10.1016/j.pcad.2020.02.014. Epub 2020 Feb 25.
3
Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics.运用以人为本的设计方法，对艾滋病诊所中以护士为主导的心血管疾病预防干预措施进行调整。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):92-100. doi: 10.1016/j.pcad.2020.02.013. Epub 2020 Feb 21.
4
Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.降低 HIV 感染者的心血管风险：HIV 行为经济学研究中增加他汀类药物处方的理由和设计（INSPIRE）随机对照试验。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):109-117. doi: 10.1016/j.pcad.2020.02.012. Epub 2020 Feb 19.
5
Protocol paper: Stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV.方案文件：采用逐步楔形集群随机试验将 ABCS 转化为优化艾滋病毒感染者心血管护理。
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):125-133. doi: 10.1016/j.pcad.2020.02.003. Epub 2020 Feb 5.
6
Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD).基于护士主导的干预措施以扩大心血管疾病预防试验（EXTRA-CVD）中 HIV 治疗环节的理由和设计。
Am Heart J. 2019 Oct;216:91-101. doi: 10.1016/j.ahj.2019.07.005. Epub 2019 Jul 18.
7
"Get Ready and Empowered About Treatment" (GREAT) Study: a Pragmatic Randomized Controlled Trial of Activation in Persons Living with HIV.“准备并获得治疗”（GREAT）研究：一项针对 HIV 感染者的激活的实用随机对照试验。
J Gen Intern Med. 2019 Sep;34(9):1782-1789. doi: 10.1007/s11606-019-05102-7. Epub 2019 Jun 25.
8
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.HIV 感染者的心血管疾病特征、预防和管理：美国心脏协会的科学声明。
Circulation. 2019 Jul 9;140(2):e98-e124. doi: 10.1161/CIR.0000000000000695. Epub 2019 Jun 3.
9
RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review.RE-AIM规划与评估框架：历经20年回顾，适应新科学与实践
Front Public Health. 2019 Mar 29;7:64. doi: 10.3389/fpubh.2019.00064. eCollection 2019.
10
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019 ACC/AHA 心血管疾病一级预防指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2019 Sep 10;140(11):e563-e595. doi: 10.1161/CIR.0000000000000677. Epub 2019 Mar 17.
Zotero 插件